Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Conventional Therapy at Different Periods: A Meta-Analysis of Randomized Controlled Trials

AIMS: To assess the safety of ertugliflozin in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with conventional therapy at different periods. METHODS: We searched PubMed, Embase, and The Cochrane Library from inception to September 23, 2020. A total of six studies involving 41...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jing, Xiong, Shuyuan, Ding, Shenglan, Cheng, Qingfeng, Liu, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831274/
https://www.ncbi.nlm.nih.gov/pubmed/33532502
http://dx.doi.org/10.1155/2020/9704659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831274/
https://www.ncbi.nlm.nih.gov/pubmed/33532502
http://dx.doi.org/10.1155/2020/9704659

Ejemplares similares